CHR

SNP

EA

OA

前列腺增生

勃起功能障碍

F

β

SE

p

β

SE

p

5

rs10068678

T

C

−0.06621

0.012033

3.74E−08

−0.0176

0.0193

0.3629

30.27895

19

rs11084596

C

T

−0.12072

0.012265

7.38E−23

−0.005

0.0204

0.8057

96.87438

10

rs113524473

G

A

0.153177

0.027964

4.31E−08

0.0581

0.1871

0.756

30.00416

8

rs13276836

C

A

0.065416

0.011995

4.94E−08

0.0093

0.0196

0.6348

29.73993

2

rs145464945

C

A

0.113548

0.017402

6.80E−11

0.06

0.0554

0.2793

42.57391

19

rs17632542

C

T

−0.19177

0.02371

6.06E−16

−0.0494

0.0381

0.1942

65.41516

11

rs192982361

C

T

−0.13298

0.02298

7.18E−09

0.0582

0.0885

0.510301

33.48495

2

rs2457660

T

C

−0.07898

0.012075

6.12E−11

−0.0109

0.0202

0.5875

42.78254

21

rs2836750

G

T

−0.07313

0.011874

7.33E−10

−0.0354

0.0205

0.084721

37.92902

3

rs2871960

C

A

0.070902

0.011819

1.99E−09

−0.007

0.0195

0.7205

35.98428

6

rs3130623

T

C

−0.09025

0.015341

4.02E−09

0.0283

0.0244

0.2465

34.61369

8

rs366991

G

A

−0.08678

0.012823

1.31E−11

−0.0021

0.0201

0.9175

45.79596

5

rs370348

G

A

−0.09021

0.011826

2.38E−14

0.0268

0.0194

0.167

58.18928

5

rs4869246

C

T

0.074664

0.012473

2.15E−09

−0.0021

0.0202

0.9168

35.83201

2

rs59427754

A

C

−0.17629

0.032149

4.17E−08

−0.0695

0.0881

0.4304

30.06823

16

rs61185428

G

A

0.117403

0.01825

1.25E−10

0.0473

0.0415

0.2547

41.38515

5

rs671044

A

G

0.132515

0.023895

2.93E−08

0.0422

0.033

0.2006

30.75529

8

rs73686991

T

C

−0.10962

0.019281

1.31E−08

0.0301

0.0282

0.2854

32.31917

10

rs7905955

G

A

−0.11574

0.01532

4.19E−14

−0.0327

0.0226

0.1478

57.07773

18

rs8097576

C

T

−0.07191

0.01192

1.61E−09

0.0077

0.02

0.7011

36.39522

7

rs9655205

A

C

−0.09738

0.01433

1.08E−11

−0.0332

0.0233

0.1551

46.17729

13

rs987086

T

C

−0.08112

0.012847

2.71E−10

−0.0451

0.0221

0.04118

39.87397

17

rs9901746

G

A

−0.08203

0.011944

6.50E−12

−0.0221

0.02

0.2678

47.17037